| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |